Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for EZOGABINE
- An Open-Label Extension of the Study XEN496 (Ezogabine) in Children With KCNQ2-DEE
- XEN496 (Ezogabine) in Children With KCNQ2 Developmental and Epileptic Encephalopathy
- Study to Treat Major Depressive Disorder With a New Medication
- Perampanel for Treatment of Adults With Refractory Focal Epilepsy : a Pilot Study.
- Clinical Trial of Ezogabine (Retigabine) in ALS Subjects
- Study to Treat Major Depressive Disorder (MDD) With a New Medication
- Cortical Excitability Changes Induced by Retigabine: a Transcranial Magnetic Stimulation Study
- Dose-Optimization, Adjunctive Treatment Study of Ezogabine/Retigabine Immediate Release in Partial-onset Seizures
- Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS
- An Open Label Study to Evaluate the Effects of Ezogabine/Retigabine Added to Existing Anti-epileptic Drug(s) on Urinary Voiding Function in Subjects With Partial Onset Seizures
- An Open-label, Single-centre Study Evaluating the Pharmacokinetics of Digoxin Alone and When Administered at Various Doses of Ezogabine/Retigabine in Healthy Adults. The Pharmacokinetics of Ezogabine/Retigabine and the N-acetyl Metabolite of Ezogabi
- Study in Pediatric Subjects With Epilepsy
- Effect of Haemodialysis on the Pharmacokinetics of Ezogabine/Retigabine and Its N-acetyl Metabolite
- Crossover Study to Evaluate the Pharmacokinetics of Ezogabine/Retigabine in Taiwanese Subjects
- Risk of Urinary Retention With Retigabine
- An Open Label, Randomised, Repeat Dose Study to Assess the Pharmacokinetic Performance of Five Ezogabine/Retigabine Modified Release (MR) Formulations at Steady State Compared to the Immediate Release (IR) Formulation.
Clinical trials list
click for details